98 related articles for article (PubMed ID: 19155102)
1. No association of lipase C polymorphisms with Alzheimer's disease.
Laws SM; Eckart K; Friedrich P; Eisele T; Kurz A; Förstl H; Riemenschneider M
Neurobiol Aging; 2010 Dec; 31(12):2192-3. PubMed ID: 19155102
[TBL] [Abstract][Full Text] [Related]
2. No association of vacuolar protein sorting 26 polymorphisms with Alzheimer's disease.
Riemenschneider M; Schoepfer-Wendels A; Friedrich P; Konta L; Laws SM; Mueller JC; Kurz A; Förstl H
Neurobiol Aging; 2007 Jun; 28(6):883-4. PubMed ID: 16784798
[TBL] [Abstract][Full Text] [Related]
3. Three SNPs in the GSTO1, GSTO2 and PRSS11 genes on chromosome 10 are not associated with age-at-onset of Alzheimer's disease.
Ozturk A; Desai PP; Minster RL; Dekosky ST; Kamboh MI
Neurobiol Aging; 2005; 26(8):1161-5. PubMed ID: 15917099
[TBL] [Abstract][Full Text] [Related]
4. No association of Tachykinin receptor 2 (TACR2) polymorphisms with Alzheimer's disease.
Friedrich P; Feulner TM; Laws SM; Eckart K; Perneczky R; Kurz A; Förstl H; Riemenschneider M
Neurobiol Aging; 2011 Mar; 32(3):544-5. PubMed ID: 19375820
[TBL] [Abstract][Full Text] [Related]
5. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
[TBL] [Abstract][Full Text] [Related]
6. Lack of genetic association between PPARG gene polymorphisms and Finnish late-onset Alzheimer's disease.
Helisalmi S; Tarvainen T; Vepsäläinen S; Koivisto AM; Hiltunen M; Soininen H
Neurosci Lett; 2008 Aug; 441(2):233-6. PubMed ID: 18573313
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in N-methyl-D-aspartate receptor subunit NR3A but not NR3B influences susceptibility to Alzheimer's disease.
Liu HP; Lin WY; Liu SH; Wang WF; Tsai CH; Wu BT; Wang CK; Tsai FJ
Dement Geriatr Cogn Disord; 2009; 28(6):521-7. PubMed ID: 20016182
[TBL] [Abstract][Full Text] [Related]
8. BDNF genetic variations increase the risk of Alzheimer's disease-related depression.
Borroni B; Grassi M; Archetti S; Costanzi C; Bianchi M; Caimi L; Caltagirone C; Di Luca M; Padovani A
J Alzheimers Dis; 2009; 18(4):867-75. PubMed ID: 19661618
[TBL] [Abstract][Full Text] [Related]
9. Association of IL10 promoter polymorphism in Italian Alzheimer's disease.
Bagnoli S; Cellini E; Tedde A; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
Neurosci Lett; 2007 May; 418(3):262-5. PubMed ID: 17420099
[TBL] [Abstract][Full Text] [Related]
10. PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.
Belbin O; Beaumont H; Warden D; Smith AD; Kalsheker N; Morgan K
Neurobiol Aging; 2009 Dec; 30(12):1992-9. PubMed ID: 18403054
[TBL] [Abstract][Full Text] [Related]
11. Lack of association of hepatic lipase polymorphisms with late-onset Alzheimer's disease.
Zhu H; Taylor JW; Bennett DA; Younkin SG; Estus S
Neurobiol Aging; 2008 May; 29(5):793-4. PubMed ID: 17175070
[TBL] [Abstract][Full Text] [Related]
12. The PPAR-alpha gene in Alzheimer's disease: lack of replication of earlier association.
Sjölander A; Minthon L; Bogdanovic N; Wallin A; Zetterberg H; Blennow K
Neurobiol Aging; 2009 Apr; 30(4):666-8. PubMed ID: 17850927
[TBL] [Abstract][Full Text] [Related]
13. Genetic association between CALHM1, 2, and 3 polymorphisms and Alzheimer's disease in a Japanese population.
Shibata N; Kuerban B; Komatsu M; Ohnuma T; Baba H; Arai H
J Alzheimers Dis; 2010; 20(2):417-21. PubMed ID: 20164573
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.
Capurso C; Solfrizzi V; Colacicco AM; D'Introno A; Frisardi V; Imbimbo BP; Lorusso M; Vendemiale G; Denitto M; Santamato A; Seripa D; Pilotto A; Fiore P; Capurso A; Panza F
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):177-82. PubMed ID: 19897004
[TBL] [Abstract][Full Text] [Related]
15. Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease.
Zhang Q; Yu JT; Zhu QX; Zhang W; Wu ZC; Miao D; Tan L
Brain Res; 2010 Aug; 1348():216-21. PubMed ID: 20558149
[TBL] [Abstract][Full Text] [Related]
16. Study of thyroid hormone receptor alpha gene polymorphisms on Alzheimer's disease.
Goumidi L; Flamant F; Lendon C; Galimberti D; Pasquier F; Scarpini E; Hannequin D; Campion D; Amouyel P; Lambert JC; Meirhaeghe A
Neurobiol Aging; 2011 Apr; 32(4):624-30. PubMed ID: 19427062
[TBL] [Abstract][Full Text] [Related]
17. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
[TBL] [Abstract][Full Text] [Related]
18. Influence of lysosomal acid lipase polymorphisms on chromosome 10 on the risk of Alzheimer's disease and cholesterol metabolism.
von Trotha KT; Heun R; Schmitz S; Lütjohann D; Maier W; Kölsch H
Neurosci Lett; 2006 Jul; 402(3):262-6. PubMed ID: 16730122
[TBL] [Abstract][Full Text] [Related]
19. Gene variations in GSTM3 are a risk factor for Alzheimer's disease.
Hong GS; Heun R; Jessen F; Popp J; Hentschel F; Kelemen P; Schulz A; Maier W; Kölsch H
Neurobiol Aging; 2009 May; 30(5):691-6. PubMed ID: 17904251
[TBL] [Abstract][Full Text] [Related]
20. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele.
Riemenschneider M; Schwarz S; Wagenpfeil S; Diehl J; Müller U; Förstl H; Kurz A
Mol Psychiatry; 2002; 7(7):782-5. PubMed ID: 12192623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
